Cohen Lawrence B lifted its stake in Danaher Co. (NYSE:DHR) by 8.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,645 shares of the conglomerate’s stock after acquiring an additional 545 shares during the quarter. Cohen Lawrence B’s holdings in Danaher were worth $950,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in DHR. Geode Capital Management LLC raised its position in shares of Danaher by 8.4% during the 4th quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock valued at $774,743,000 after buying an additional 583,194 shares in the last quarter. Capital Investment Advisors LLC bought a new position in shares of Danaher during the 1st quarter valued at $215,000. Virtu Financial LLC bought a new position in shares of Danaher during the 1st quarter valued at $958,000. Strategic Advisors LLC grew its holdings in shares of Danaher by 14.5% during the 1st quarter. Strategic Advisors LLC now owns 2,879 shares of the conglomerate’s stock valued at $380,000 after purchasing an additional 364 shares during the last quarter. Finally, Palisade Asset Management LLC grew its holdings in shares of Danaher by 36.9% during the 1st quarter. Palisade Asset Management LLC now owns 23,804 shares of the conglomerate’s stock valued at $3,143,000 after purchasing an additional 6,414 shares during the last quarter. Hedge funds and other institutional investors own 79.35% of the company’s stock.
In other news, EVP Daniel L. Comas sold 7,726 shares of Danaher stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $132.41, for a total transaction of $1,022,999.66. Following the sale, the executive vice president now owns 119,095 shares of the company’s stock, valued at approximately $15,769,368.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP William K. Daniel sold 164,164 shares of Danaher stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $132.43, for a total transaction of $21,740,238.52. Following the sale, the executive vice president now directly owns 194,627 shares in the company, valued at approximately $25,774,453.61. The disclosure for this sale can be found here. Insiders have sold a total of 392,121 shares of company stock worth $53,603,339 in the last ninety days. Insiders own 11.40% of the company’s stock.
Shares of DHR opened at $140.54 on Wednesday. The company’s 50-day moving average is $141.56. The company has a market cap of $100.65 billion, a price-to-earnings ratio of 31.09, a price-to-earnings-growth ratio of 2.53 and a beta of 0.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.32 and a quick ratio of 1.91. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $145.50.
Danaher (NYSE:DHR) last announced its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.04. The firm had revenue of $5.16 billion for the quarter, compared to analyst estimates of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.15 EPS. As a group, sell-side analysts expect that Danaher Co. will post 4.79 earnings per share for the current fiscal year.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: What is the operating income formula?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.